I walked in expecting the nominee to be the one throwing punches. Heidi Overton stood beside Trump in August as he signed the order cutting the childhood vaccine schedule, the one GOP physician Bill Cassidy called “almost disqualifying,” so I assumed she would come to the Senate and defend it disease by disease. Instead she spent two hours telling senators that every vaccine on the U.S. market is safe and effective, according to the FDA. The reform nominee showed up to her own confirmation and recited the establishment’s line.

She is no bystander to this fight. Overton is the preventive-medicine physician who runs health policy inside Trump’s domestic-policy shop, came up through the America First Policy Institute’s health center, and coordinated the interagency process behind the vaccine order itself. Pressed on why she stood alongside the president at the signing, she described her job as taking “the president’s directive” and providing “options to him.” This is someone who has spent years arguing American health policy is broken, which is exactly why watching her go quiet under oath was the surprise.

Chris Murphy, Democrat of Connecticut, said it plainly: “You’ve done a pretty good job of avoiding answering questions so far.” He was right. Every time a senator reached for a real position, she reached back for the FDA’s existing findings. Is mifepristone safe? It “has met FDA safety and efficacy standards.” Does Tylenol in pregnancy cause autism, as the president has suggested? She had “seen no evidence” of it. Would she stand up to the White House? She would “follow the law.” Two hours of a very smart person saying almost nothing.

The science underneath the fight is far more interesting than the theater on top of it. The order Overton coordinated cuts the universally recommended childhood vaccine list from the 18 diseases on the CDC’s 2024 schedule to 11, pushing shots for COVID, rotavirus, flu, hepatitis A, hepatitis B, and bacterial meningitis out of the automatic column and into shared decision-making between a parent and a doctor. Its stated reason is a number I keep turning over: the United States recommends more childhood vaccines than any peer nation, in some cases more than twice the doses of comparable European countries. So which is it? Are Germany and the Netherlands quietly running an experiment on their kids, or are we the outlier that never stopped to ask why the list only ever grows?

That is the question the establishment works hard not to answer, and you can watch the dodge happen in real time. Cassidy, a physician, said the order rested on “zero” scientific evidence and told parents to trust their pediatrician over it. But look at which argument he swats. The president muddied his own case by suggesting shots “overwhelm” a child’s immune system, and that one is easy to knock down: a young child’s immune system meets an enormous load of everyday microbial exposures, and the antigens in the schedule are a rounding error against that. The immunologists win that fight every time. The trouble is that immune-overwhelm was never the strong argument.

The strong argument is disease by disease, and it is the uncomfortable one. Take the hepatitis B shot given on day one of life. Hepatitis B spreads through blood, sex, and from an infected mother to her baby at birth, and that last route is the real reason a birth dose exists at all. But mothers are already screened for hepatitis B during pregnancy. So the honest question is why the newborn of a screened, negative mother, at essentially no risk, still gets a universal day-one dose for a virus she has no way to catch. Or take COVID: why a blanket recommendation for healthy two-year-olds, whose absolute risk of severe outcomes was always a small fraction of what older or medically fragile people faced? Reasonable people land in different places on these. What they should not do is pretend the questions are illiterate.

The order is not all clean, either. It calls for splitting the combined MMR into three separate single-disease shots and spacing childhood immunizations across separate visits, a change that in practice could more than double the number of pediatric appointments. The catch is that standalone measles, mumps, and rubella vaccines are not sold in the U.S. today, so “more choice” here means more needles, not fewer. It also stands up an HHS task force on “safer” childhood vaccines and points the Justice Department at state mandate laws. Some of that is the parental-authority argument this publication has made for years. Some of it is a directive with no product behind it. A commissioner who actually believed in the reform could stand up and separate the real from the performative. Asked point-blank, Overton instead affirmed that the MMR vaccine is “safe and effective” and “not lethal,” called it the “best tool” against the current measles outbreak, and said every unvaccinated American should get it. Fine. But that is the answer of someone auditioning for the establishment’s approval, not someone planning to reform the agency that hands it out.

Which brings me to the word everyone in that room kept reaching for: independence. The senators pressing her wanted a promise she would defy Trump and RFK Jr. But the FDA’s independence problem did not start this year, and it does not live in the White House. It lives in the revolving door with the drug industry the agency regulates, in the user fees from those same companies that now bankroll much of the agency’s own review staff, and in the long record of “safe and effective” stamped on products later pulled or relabeled. That is this publication’s standing view of the building, and nothing in Overton’s testimony cut against it. The real question at that table was never whether she will resist the president. It was whether she will reform a captured agency or get absorbed by it the way her predecessors did, and a nominee who spends her whole hearing behind “existing FDA guidance” has already shown you which way she leans.

So this is my conclusion, and it is not where the New York Times editorial board will land. I am not marking her down for going too far. I am marking her down for going quiet. I wanted an FDA commissioner who could look a senator in the eye and explain, under oath, why the newborn of a healthy screened mother does not need a day-one hepatitis B shot, and why the longest vaccine schedule in the developed world went untrimmed for decades until now. Overton had two hours to make that case and folded into agency boilerplate instead. I would not hand someone the keys to that building on the strength of a performance like that, and if she runs the FDA the way she testified to the Senate, I am not betting the reform she stood beside survives its first month of contact with the job.

Sources

  1. Newsweek – Trump’s FDA nominee grilled by GOP senator over childhood vaccine schedule
  2. Scientific American – Trump’s FDA nominee Heidi Overton affirms MMR vaccine and mifepristone are safe at crucial Senate hearing
  3. ABC News – Dr. Heidi Overton appears before Senate committee for FDA confirmation hearing
  4. STAT – FDA nominee Heidi Overton keeps her opinions to herself in Senate hearing
  5. NBC News – Trump order aims to cut childhood vaccine schedule from 18 diseases to 11
  6. The White House – Executive Order, “Delivering Gold Standard Childhood Vaccine Recommendations for Americans” (Aug. 2026)
  7. U.S. Senate HELP Committee – Nomination of Heidi Overton to be Commissioner of Food and Drugs